Source: Abstracts. Conference titles: Congress of the European Society of Cardiology. Unidade: FMRP
Assunto: DOENÇA DE CHAGAS
ABNT
TANAKA, Denise Mayumi et al. Severe rest myocardial defects in experimental chronic Chagas cardiomyopathy correspond to viable hypoperfused myocardium: proof-of-concept study using prolonged dipyridamole administration. 2017, Anais.. Barcelona: ESC, 2017. . Acesso em: 19 ago. 2024.APA
Tanaka, D. M., Carvalho, E. E. V. de, Oliveira, L. F. L. de, Romano, M. M. D., Lopes, C. D., Barros Filho, A. C. L. de, et al. (2017). Severe rest myocardial defects in experimental chronic Chagas cardiomyopathy correspond to viable hypoperfused myocardium: proof-of-concept study using prolonged dipyridamole administration. In Abstracts. Barcelona: ESC.NLM
Tanaka DM, Carvalho EEV de, Oliveira LFL de, Romano MMD, Lopes CD, Barros Filho ACL de, Ribeiro FFF, Ana LW, Silva JS, Marin Neto JA, Simões MV. Severe rest myocardial defects in experimental chronic Chagas cardiomyopathy correspond to viable hypoperfused myocardium: proof-of-concept study using prolonged dipyridamole administration. Abstracts. 2017 ;[citado 2024 ago. 19 ]Vancouver
Tanaka DM, Carvalho EEV de, Oliveira LFL de, Romano MMD, Lopes CD, Barros Filho ACL de, Ribeiro FFF, Ana LW, Silva JS, Marin Neto JA, Simões MV. Severe rest myocardial defects in experimental chronic Chagas cardiomyopathy correspond to viable hypoperfused myocardium: proof-of-concept study using prolonged dipyridamole administration. Abstracts. 2017 ;[citado 2024 ago. 19 ]